ICYMI: The PASTEUR Act was reintroduced in the Senate. Plus, more from BIO 2026, including the latest on the 340B program and what the media was covering at the Convention. (639 words, 3 minutes, 12 ...

The Prescription Drug User Fee Act (PDUFA) is a cornerstone of the U.S. regulatory framework that helps ensure patients have timely access to safe and effective new medicines. Enacted by Congress in ...

BIO 2026 features more than 150 sessions and 950+ speakers across 18 focus areas — from AI and digital health to diagnostics and personalized medicine, emerging opportunities in global markets, and ...

The "Product & Company Valuation" course is designed to teach a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals, or strategic ...

The contents of the member listings on the BIO Web site may not be reproduced or used in any form without prior written permission from BIO. For more information about members, please refer to the ...

Patient groups happy Virginia won't have a PDAB. Plus, seeking clarity about onshoring agreements. (789 words, 3 minutes, 10 seconds) Patient advocates praised Virginia Gov. Abigail Spanberger’s veto ...

Lawmakers defended strong IP protections as essential to biotech innovation in a June 4 Congressional hearing that also considered the role of generics and biosimilars. Proposals to weaken IP in order ...